These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 19427502)

  • 1. Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches.
    Reisin E; Jack AV
    Med Clin North Am; 2009 May; 93(3):733-51. PubMed ID: 19427502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension in obesity.
    Redon J
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):344-53. PubMed ID: 11887431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal consequences of obesity.
    Naumnik B; Myśliwiec M
    Med Sci Monit; 2010 Aug; 16(8):RA163-70. PubMed ID: 20671624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Obesity-related hypertension].
    Dorresteijn JA; Visseren FL; van den Meiracker AH; Spiering W
    Ned Tijdschr Geneeskd; 2011; 154():A1945. PubMed ID: 21418695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hypertension in obesity].
    Scholze J; Sharma AM
    Herz; 2001 May; 26(3):209-21. PubMed ID: 11413801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The heart in obesity-hypertension.
    Morse SA; Bravo PE; Morse MC; Reisin E
    Expert Rev Cardiovasc Ther; 2005 Jul; 3(4):647-58. PubMed ID: 16076275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Obesity and cardiovascular diseases-theoretical background and therapeutic consequences].
    Völler H; Schmailzl KJ; Bjarnason-Wehrens B
    Z Kardiol; 2004 Jul; 93(7):503-13. PubMed ID: 15243761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic considerations in hypertension.
    Tuck ML
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):355S-365S. PubMed ID: 2078323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity-related hypertension: its physiological basis and pharmacological approaches to its treatment.
    Richards RJ; Thakur V; Reisin E
    J Hum Hypertens; 1996 Sep; 10 Suppl 3():S59-64. PubMed ID: 8872829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of obesity-related hypertension].
    Skoczylas A
    Wiad Lek; 2006; 59(5-6):403-6. PubMed ID: 17017491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obesity and cardiac failure].
    Galinier M; Pathak A; Roncalli J; Massabuau P
    Arch Mal Coeur Vaiss; 2005 Jan; 98(1):39-45. PubMed ID: 15724418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hypertension in the patients with obesity].
    Hano T; Nishio I
    Nihon Rinsho; 2001 May; 59(5):973-7. PubMed ID: 11392001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity-hypertension: the effects on cardiovascular and renal systems.
    Zhang R; Reisin E
    Am J Hypertens; 2000 Dec; 13(12):1308-14. PubMed ID: 11130776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity and hypertension.
    Mikhail N; Golub MS; Tuck ML
    Prog Cardiovasc Dis; 1999; 42(1):39-58. PubMed ID: 10505492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertension and cardiomyopathy in obesity. Treat the heart simultaneously].
    Wirth A
    MMW Fortschr Med; 2001 Oct; 143(42):39-42. PubMed ID: 11697285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of arterial hypertension in obese patients.
    Wenzel UO; Benndorf R; Lange S
    Semin Nephrol; 2013 Jan; 33(1):66-74. PubMed ID: 23374895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and difficult to treat arterial hypertension.
    Jordan J; Yumuk V; Schlaich M; Nilsson PM; Zahorska-Markiewicz B; Grassi G; Schmieder RE; Engeli S; Finer N
    J Hypertens; 2012 Jun; 30(6):1047-55. PubMed ID: 22573071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal and cardiovascular considerations for the nonpharmacological and pharmacological therapies of obesity-hypertension.
    Zhang R; Thakur V; Morse S; Reisin E
    J Hum Hypertens; 2002 Dec; 16(12):819-27. PubMed ID: 12522462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.